These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 5567270)
21. [Zinc-protamine-glucagon in the therapy of heart failure]. Kaindl F; Kühn P Z Gesamte Inn Med; 1972 Dec; 27(24):1097-8. PubMed ID: 4654564 [No Abstract] [Full Text] [Related]
22. [Glucagon in heart failure]. Riecker G Dtsch Med Wochenschr; 1974 May; 99(22):1206. PubMed ID: 4151692 [No Abstract] [Full Text] [Related]
23. Effect of glucagon on dogs with acute and chronic heart block. Hurwitz RA Am Heart J; 1971 May; 81(5):644-9. PubMed ID: 5552067 [No Abstract] [Full Text] [Related]
25. [Action of glucagon on the cardiovascular system and its possible use in cardiological therapy]. Sgarbi M; Vaona P; Neri M Minerva Cardioangiol; 1974 Jun; 22(6):481-9. PubMed ID: 4847337 [No Abstract] [Full Text] [Related]
26. Glucagon: its enhancement of cardiac performance in the cat with chronic heart failure. Nobel-Allen N; Kirsch M; Lucchesi BR J Pharmacol Exp Ther; 1973 Dec; 187(3):475-81. PubMed ID: 4770394 [No Abstract] [Full Text] [Related]
28. Effects of glucagon on atrioventricular conduction and ventricular automaticity in dogs. Steiner C; Wit AL; Damato AN Circ Res; 1969 Feb; 24(2):167-77. PubMed ID: 5812676 [No Abstract] [Full Text] [Related]
29. [Contribution to the konwledge of some effects of proscillaridin on the cardiovascular system. Electrocardiographic and radiocardiographic research]. Sorrentino F; Musco A; Cascone O; Modica G Clin Ter; 1966 Jul; 38(1):39-48. PubMed ID: 5990470 [No Abstract] [Full Text] [Related]
31. Indications, contraindications, and nonindications for digitalis therapy. Duca P; Brest AN Cardiovasc Clin; 1974; 6(2):131-40. PubMed ID: 4613456 [No Abstract] [Full Text] [Related]
32. [Glucagon and its importance in clinical practice]. Anisimov VE Klin Med (Mosk); 1974 Jul; 52(7):12-8. PubMed ID: 4603563 [No Abstract] [Full Text] [Related]
33. [Injectable diphenylhydantoin in cardiology. Experimental study]. Quiret JC; Bens JL; Duboisset M; Lesbre P; Bernasconi P Arch Mal Coeur Vaiss; 1974 Jan; 67(1):87-96. PubMed ID: 4211204 [No Abstract] [Full Text] [Related]
34. [Electrophysiological effects of nifedipine in humans. Preliminary note]. Disertori M; Molinis G; Antonini L; Furlanello F Minerva Cardioangiol; 1978 Nov; 26(11):713-9. PubMed ID: 724117 [No Abstract] [Full Text] [Related]
35. [Cardiac action of glucagon in patients with heart diseases]. Hermann HJ; Sanmarco ME; Meyers SN Prensa Med Argent; 1971 Jul; 58(22):1079-85. PubMed ID: 5097750 [No Abstract] [Full Text] [Related]
36. [Cardiovascular effects of glucagon]. Seitz N Internist (Berl); 1971 May; 12(5):222-3. PubMed ID: 4931507 [No Abstract] [Full Text] [Related]
37. Pharmacologic basis for the treatment of cardiac arrhythmias. Gelband H; Rosen MR Pediatrics; 1975 Jan; 55(1):59-67. PubMed ID: 1089243 [No Abstract] [Full Text] [Related]
38. [Hemodynamic effects of glucagon in acute myocardial infarct, total A-V block and mitral stenosis]. Gavrilescu S; Streian C; Pop T; Vicaş E Med Interna (Bucur); 1971 May; 23(5):573-82. PubMed ID: 5567983 [No Abstract] [Full Text] [Related]
39. [Cardiac arrhythmias. Types and drug therapy (author's transl)]. Lehmann HU MMW Munch Med Wochenschr; 1981 Apr; 123(17):680-6. PubMed ID: 6164919 [TBL] [Abstract][Full Text] [Related]
40. Hemodynamic effect of glucagon in patients with chronic complete heart block. Gavrilescu S; Streian C; Pop T; Vicas E Cor Vasa; 1971; 13(2):85-91. PubMed ID: 5570405 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]